The Alliance for Regenerative Medicine (ARM) and the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) produced A-Cell, a case study-based guide to integrating Quality by design (QbD) principles in cell therapy Chemistry Manufacturing & Control (CMC) programs.
A press release for this project is available here; upcoming and on-demand webinars can be found here.
